Nalbuphine and Flurbiprofen for Oculoplastic Surgery

Flurbiprofen Axetil and Nalbuphine for Postoperative Pain and Discomfort After Oculoplastic Surgery

The purpose of this study is to evaluate the postoperative pain and discomfort using flurbiprofen axetil or nalbuphine administration after oculoplastic surgery under general anesthesia.

In this randomized controlled clinical trial, we evaluated the postoperative analgesic efficacy and adverse effects of flurbiprofen axetil combined with nalbuphine in patients undergoing oculoplastic surgery compared with a single dose of flurbiprofen axetil or nalbuphine.

Inclusion Criteria:

• Undergoing oculoplastic surgery
• age between 16 and 75 years
• American Society of Anesthesiologists (ASA) physical status of I-II

Exclusion Criteria:

• serious coexisting disease
• body mass index (BMI) <18.5 or >35
• contraindications or previous adverse reactions to any of the drugs used
• females with a positive pregnancy test
• patients unable to cooperate